Table 1:
Baseline clinical characteristics of hospitalized COVID-19 patient cohort
| Cancer Patients (N=36) | |||
|---|---|---|---|
| All Cancer N=36 | Any GI symptoms N=23 | No GI symptoms N=13 | |
| Age (years, ± SD) | 64.1±14.6 | 61.1±15.5 | 69.3±11.7 |
| Female, n (%) | 18 (50.0) | 13 (56.5) | 5 (38.5) |
| Body mass index (kg/m2, ± SD) | 28.8±5.0 | 28.9±4.6 | 28.7±6.0 |
| Medical History, n (%) | |||
| Coronary artery disease | 3 (8.3) | 2 (8.7) | 1 (7.7) |
| Congestive heart failure | 3 (8.3) | 3 (13.0) | 0 (0) |
| Cardiac arrhythmia | 4 (17.4) | 2 (8.7) | 4 (30.8) |
| Hypertension | 20 (55.6) | 11 (47.8) | 9 (69.2) |
| Hyperlipidemia | 10 (27.8) | 8 (34.8) | 2 (15.4) |
| Diabetes | 8 (22.2) | 3 (13.0) | 5 (38.5) |
| Cerebrovascular accident | 2 (5.6) | 2 (8.7) | 0 (0) |
| Pulmonary disorders | 11 (30.6) | 6 (26.1) | 5 (38.5) |
| Chronic renal insufficiency | 3 (8.6) | 2 (9.1) | 1 (7.7) |
| Thyroid disorder | 3 (8.3) | 2 (8.7) | 1 (7.7) |
| Gastroesophageal reflux disease | 14 (38.9) | 9 (39.2) | 5 (38.5) |
| Irritable bowel syndrome | 0 (0) | 0 (0) | 0 (0) |
| Inflammatory bowel disease | 0 (0) | 0 (0) | 0 (0) |
| Peptic ulcer disease | 0 (0) | 0 (0) | 0 (0) |
| Cancer site | |||
| Lung cancer | 7 (19.4) | 5 (21.7) | 2 (15.4) |
| Leukemia | 5 (13.9) | 1 (4.3) | 4 (30.8) |
| Lymphoma | 4 (11.1) | 3 (13.0) | 1 (7.7) |
| Breast | 4 (11.1) | 3 (13.0) | 1 (7.7) |
| Melanoma | 3 (8.3) | 1 (4.3) | 2 (15.4) |
| Colorectal cancer | 2 (5.6) | 1 (4.3) | 1 (7.7) |
| Hepatocellular carcinoma | 2 (5.6) | 2 (8.7) | 0 (0) |
| Other | 9 (25.0) | 5 (21.7) | 4 (30.8) |
| Glioblastoma multiforme | 1 (2.8) | 1 (4.3) | 0 (0) |
| Esophageal adenocarcinoma | 1 (2.8) | 1 (4.3) | 0 (0) |
| Cholangiocarcinoma | 1 (2.8) | 1 (4.3) | 0 (0) |
| Sarcoma | 1 (2.8) | 1 (4.3) | 0 (0) |
| Gastric gastrointestinal stromal | 1 (2.8) | 1 (4.3) | 0 (0) |
| tumor (GIST) | 1 (2.8) | 0 (0) | 1 (7.7) |
| Gastric neuroendocrine tumor | 1 (2.8) | 0 (0) | 1 (7.7) |
| Prostate | 1 (2.8) | 0 (0) | 1 (7.7) |
| Multiple myeloma | 1 (2.8) | 0 (0) | 1 (7.7) |
| Vaginal squamous cell | |||
| Social History, n (%) | 4 (11.4) | 3 (13.6) | 1 (7.7) |
| Alcohol use | 6 (16.7) | 5 (21.7) | 1 (7.7) |
| Tobacco use | |||